{"title":"[欧洲风湿病联盟第六届年会报告,雅典,1990年5月17日。]萘普生——风湿病治疗的标准。证实一种经过试验和测试的非甾体抗风湿药[NSAR]。","authors":"","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":77137,"journal":{"name":"Fortschritte der Medizin. Supplement : die Kongressinformation fur die Praxis","volume":"96 ","pages":"1-15"},"PeriodicalIF":0.0000,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Report of the 6th annual meeting of the European League Against Rheumatism, Athens, May 17, 1990. Naproxen--standard in rheumatism therapy. Confirmation of a tried and tested non-steroidal anti-rheumatic drug (NSAR)].\",\"authors\":\"\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":77137,\"journal\":{\"name\":\"Fortschritte der Medizin. Supplement : die Kongressinformation fur die Praxis\",\"volume\":\"96 \",\"pages\":\"1-15\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1990-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Fortschritte der Medizin. Supplement : die Kongressinformation fur die Praxis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fortschritte der Medizin. Supplement : die Kongressinformation fur die Praxis","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Report of the 6th annual meeting of the European League Against Rheumatism, Athens, May 17, 1990. Naproxen--standard in rheumatism therapy. Confirmation of a tried and tested non-steroidal anti-rheumatic drug (NSAR)].